The global companion animal vaccines market is set for significant expansion, according to a recent study by Future Market Insights, Inc. Valued at USD 3.4 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 6.8%, reaching over USD 6.7 billion by 2033.
This remarkable growth trajectory is fueled by a combination of pivotal factors transforming the companion animal healthcare sector. The trend towards the humanization of pets is driving pet owners to allocate greater resources towards the health and well-being of their animal companions. This is further supported by a growing awareness of pet insurance, which encourages comprehensive healthcare measures, including vaccinations.
Achieve Business Milestones with Informed Strategies: Access Request Checkout Now
“The global market for companion animal vaccines is witnessing robust growth driven by the convergence of factors such as pet humanization, increased awareness about pet health insurance, and the escalating incidence of animal diseases,” stated a Future Market Insights.
Vaccination remains pivotal in mitigating the spread of infectious diseases among companion animals, contributing significantly to their overall health and longevity. In developed nations, rigorous vaccination programs have already proven successful in eradicating many chronic diseases, underscoring the importance of preventive healthcare measures for pets.
As the market continues to evolve, pharmaceutical companies and veterinary professionals are expected to collaborate more closely to develop innovative vaccines and broaden their distribution networks, thereby meeting the growing demand for companion animal healthcare solutions worldwide.
The passage outlines two main restraining factors for the companion animal vaccines market:
Shift in Sales Channels:
- The Fairness to Pet Owners Act allows pet owners to purchase vaccines from retailers and pharmacies, bypassing veterinarians.
- This reduces the market share traditionally held by veterinarians and forces vaccine companies to adapt their sales strategies.
- The shift might also affect profit margins due to changes in distribution channels and consolidation of veterinary clinics.
Knowledge Gaps in Disease Epidemiology:
- Lack of understanding about the prevalence and spread of veterinary diseases, particularly in endemic countries, hinders vaccine development.
- The example of Newcastle Disease in poultry highlights this issue.
- Rapid mutations and variations in the virus make it difficult to develop effective vaccines, limiting the market potential.
Instant Report Access – Empower Your Strategy with Key Insights
Competition Analysis:
- Bayer Healthcare
- Vétoquinol S.A
- Boehringer Ingelheim
- Ceva Santé Animale
- Eli Lilly and Company
- Heska Corp.
- Merck Animal Health
- Sanofi
- Virbac
- Pfizer
Companion Animal Vaccines Market Segmentation
By Product Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species Types:
- Canine
- Avian
- Feline
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
